Application
Figure 1: Western blot analysis using ER-alpha mouse mAb against human breast carcinoma tissue lysate.Application
Figure 2: Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using ER-alpha mouse mAb showing nuclear expression with DAB staining.WB
(A) Expression levels of ERα and ERβ.WB
(E-F) Western blot results of NLRP3, ER, Wnt2b, and β-catenin different cells.WB
(E-F) Western blot results of NLRP3, ER, Wnt2b, and β-catenin different cells.| Product Name | ER-alpha |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | Purified recombinant fragment of human ER-alpha (410-592aa) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | ICC/IFIHCWB |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | ER ESR1 Era ESRA |
|---|---|
| Molecular Weight(MW) | N/A |
| Entrez Gene | 2099 |
|---|
Application
Figure 1: Western blot analysis using ER-alpha mouse mAb against human breast carcinoma tissue lysate.
Application
Figure 2: Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using ER-alpha mouse mAb showing nuclear expression with DAB staining.
WB
(A) Expression levels of ERα and ERβ.
WB
(E-F) Western blot results of NLRP3, ER, Wnt2b, and β-catenin different cells.
WB
(E-F) Western blot results of NLRP3, ER, Wnt2b, and β-catenin different cells.| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS containing 0.03% sodium azide. |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
